2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular …

S Halvorsen, J Mehilli, S Cassese, TS Hall… - European heart …, 2022 - academic.oup.com
Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …

RA Byrne, X Rossello, JJ Coughlan… - … Heart Journal: Acute …, 2024 - academic.oup.com
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes …

Z Ge, J Kan, X Gao, A Raza, JJ Zhang, BS Mohydin… - The Lancet, 2024 - thelancet.com
Background Following percutaneous coronary intervention with stent placement to treat
acute coronary syndromes, international clinical guidelines generally recommend dual …

Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis

M Valgimigli, F Gragnano, SJ Hong, SJ Lee, Y Suh, KH Yun, TS Kang, S Shin… - Circulation, 2024 - ahajournals.org
BACKGROUND: Stop** aspirin within 1 month after implantation of a drug-eluting stent for
ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary …